Immunovant, Inc. 4

COO Melanie Gloria sold 3,056 shares of Immunovant, Inc. common stock on August 20, 2026, as a mandatory sell-to-cover related to RSU vesting.

On August 20, 2026, Immunovant, Inc. Chief Operating Officer Melanie Gloria sold 3,056 shares of Immunovant common stock at a weighted average price of approximately $44.16 per share, for proceeds of about $135,000, in a transaction executed solely to cover tax withholding obligations arising from the August 18, 2026 vesting of a portion (6,872 RSUs) of a previously granted 109,956-RSU award. Following this mandatory sell-to-cover sale, she directly owns 219,301 shares of Immunovant common stock, and the transaction is characterized in the filing as non-discretionary and executed under the issuer’s required tax withholding procedures.

Filing Facts

CIK

1764013

Ticker

IMVT

Form

4

Source Type

fda

Accession

0001973838-26-000007

Alert Tier

5